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S U M M A R Y
Objectives: Leptospirosis is a serious neglected disease in the Paciﬁc. Because sensitive and speciﬁc
laboratory tests are largely unavailable, the burden of disease and epidemiological data are often
unreliable and do not allow informed disease prioritization and efﬁcient control. We report the use of
serum spotted on ﬁlter paper to improve the surveillance of leptospirosis in remote and resource-limited
settings.
Methods: A total of 172 acute-phase serum samples collected from patients with suspected dengue at
Yap State Hospital, Federated States of Micronesia, were spotted on ﬁlter paper and sent by regular mail
to the Institut Louis Malarde´, French Polynesia. Real-time PCR protocols for dengue and leptospirosis
conﬁrmation were performed on all specimens.
Results: A total of ﬁve leptospirosis infections were detected amongst the patients with suspected
dengue.
Conclusions: This study conﬁrms the use of ﬁlter paper as a convenient tool to improve leptospirosis
surveillance capacity in remote areas. New surveillance strategies, notably based on the regular use of
this type of tool, are essential to more adequately describe the epidemiology and burden of neglected
diseases.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Leptospirosis is a severe neglected disease in much of the
tropics, including the Paciﬁc region.1 The epidemiology and disease
burden in most endemic countries is poorly understood, largely
due to the absence of the advanced laboratory facilities that are
required for the diagnosis of acute-phase leptospirosis. Leptospi-
rosis is often clinically indistinguishable from several other acute
febrile illnesses, and laboratory conﬁrmation is essential.2,3 Novel
protocols adapted to remote and resource-poor regions are
necessary to improve the surveillance of leptospirosis and other
neglected diseases. In the present study, we evaluated the use of* Corresponding author. Tel.: +689 416 470; fax: +689 416 493.
E-mail address: dmusso@ilm.pf (D. Musso).
1201-9712  2013 The Authors. Published by Elsevier Ltd on behalf of International S
http://dx.doi.org/10.1016/j.ijid.2013.12.002serum spotted on ﬁlter paper for conﬁrmation of acute-phase
leptospirosis in a remote Paciﬁc setting.
2. Methods
One hundred seventy-two serum samples were collected for
diagnosis purposes during a dengue virus serotype 2 (DENV-2)
outbreak, from February through October 2012, from patients
presenting to Yap State Hospital, Federated States of Micronesia.
These patients had symptoms for less than 5 days. During the study
period, the diagnosis of an acute febrile illness in Yap relied on
physical examination and basic laboratory tests, including blood
count, erythrocyte sedimentation rate, urine, blood, and stool
culture, and dengue rapid diagnostic tests (Dengue Duo, Standard
Diagnostics Inc., Korea; detecting dengue virus-speciﬁc non-
structural 1 antigen (NS1Ag) and anti-dengue immunoglobulin
M and G class antibodies). Leptospirosis diagnostic testing was not
available.ociety for Infectious Diseases. Open access under CC BY-NC-ND license.
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paper (Serobuvard, LDA22; Ploufragan, France), which was then
dried at room temperature, placed into an individual Ziploc plastic
bag (Dutscher, France), and stored at 4 8C until shipment by
standard mail at ambient temperatures to the Institut Louis
Malarde´, French Polynesia.
In French Polynesia, the serum spotted on the ﬁlter paper was
submitted to nucleic acid extraction using the easyMAG extraction
system (bioMe´rieux). DENV ampliﬁcation was performed using a
TaqMan multiplex real-time reverse transcription PCR (RT-PCR),
and Leptospira ampliﬁcation was done using a TaqMan real-time
PCR targeting the lipL32 gene, as previously reported, using a
CFX96 Bio-Rad thermocycler.4,5 Two negative controls (non-
spotted ﬁlter paper and sterile water) and two positive controls
(Leptospira and DENV) were included in each run.
This study was a non-interventional study conducted on serum
initially collected for the purpose of diagnosis of an acute febrile
illness, on the medical instructions of a physician.
3. Results
Delivery of the spotted serum ﬁlter paper by standard mail to
French Polynesia took approximately 4 weeks. A DENV-2
infection was conﬁrmed by real-time RT-PCR in 15 sera: 12
had previously tested NS1Ag-positive and three had tested
NS1Ag-negative by rapid diagnosis tests in Yap. Leptospira was
detected by real-time PCR in ﬁve sera. No co-infections were
diagnosed. Ampliﬁcation was negative for all negative controls
and positive for all positive controls. Clinical features and
laboratory results for the ﬁve leptospirosis-positive patients
are reported in Table 1.
4. Discussion
Oceania exhibits a signiﬁcant burden of leptospirosis and, with
Southeast Asia, appears to have the highest incidence of thisTable 1
Laboratory and clinical features of the ﬁve leptospirosis patients
Case patient
1 2 3 4 5
Laboratory results
Leukocyte count (109 cells/l) 14.8 8.74 8.92 9.27 4.13
Polymorphonuclear (%) 71 65 69 55 97
Platelet count (109 cells/l) 267 106 138 165 113
Erythrocyte sedimentation rate 12 8 5 102 NDa
Dengue NS1Ag/IgM/IgG Nb/N/N N/N/N N/N/N N/N/N N/N/N
Leptospirosis IgM/IgG ND/ND ND/ND ND/ND ND/ND ND/ND
Clinical features
Fever Yes Yes Yes Yes Yes
Headache NAc Yes Yes NA Yes
Myalgia/arthralgia NA Yes Yes NA Yes
Nausea/vomiting NA Yes No Yes Yes
Rash or ﬂush No No No No No
Mucosal bleeding No No No No No
Liver enlargement No No No No No
Clinical ﬂuid accumulation No No No No No
Lethargy/restlessness Yes No No Yes No
Antibiotherapy AMOd No AMO 1GCe No
Duration of antibiotherapy 10 days 10 days NA
Recovery Yes Yes Yes Yes Yes
a Not determined.
b Negative.
c Not available.
d Amoxicillin.
e First-generation cephalosporin.disease.6 In addition, due to the lack of laboratory capacity, the
disease burden of leptospirosis in most of the Paciﬁc, like much of
the tropics, is underestimated and the epidemiology of the disease
is largely unknown.7 Access to accurate laboratory tests in addition
to rigorous investigational studies are necessary to evaluate the
burden of the disease. The conﬁrmation of leptospirosis is difﬁcult
in most leptospirosis-endemic countries, and a sensitive and
speciﬁc diagnostic tool for conﬁrmation of acute-phase disease is
urgently needed. Reference laboratories can offer support for the
diagnosis of leptospirosis, including PCR testing on acute-phase
samples; however, the shipment of specimens in freezing
conditions is expensive, subject to restrictive regulations, and
rarely possible from remote areas. Serum spotted on ﬁlter paper is
not subjected to dangerous goods regulation and represents a
cheap and convenient tool for sample transportation.8
We report the successful detection of ﬁve leptospirosis patients
by performing PCR on serum spotted on ﬁlter paper collected from
patients with suspected dengue. Of these patients, only two
received a ﬁrst-line leptospirosis antibiotic treatment. Thanks to
this retrospective case conﬁrmation, it was possible to alert the
local health care workers in Yap to the risk of unrecognized
leptospirosis infection during dengue outbreaks, as reported
previously.9
Because diagnostic testing of leptospirosis was not available in
Yap, it was not possible to evaluate the sensitivity of our protocol
by comparison to culture.
Many Paciﬁc island countries have limited resources to
deﬁnitively diagnose undifferentiated acute febrile illnesses, and
as a result there is a need for an efﬁcient regional surveillance
system targeting endemic and epidemic pathogens.10 The surveil-
lance protocol we have described allows remote and resource-
limited settings to collect, store, and ship samples for advanced
molecular investigations. It may also contribute to improve
locally-used diagnosis algorithms based on clinical presentation
and available laboratory tools. We conﬁrm that both viral and
bacterial diagnosis and identiﬁcation could be performed from a
single sample using serum dried on ﬁlter paper. This protocol is a
potentially powerful tool to enhance the surveillance capacity of
leptospirosis and other infectious diseases in the Paciﬁc and in
other remote or resource-poor regions. Novel diagnostic strategies
such as this protocol are essential to more adequately describe the
epidemiology and burden of leptospirosis and potentially other
neglected diseases.
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